[Activity Report] The 9th Nikkei FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC) (November 16, 2022)
- Home >
- Information >
- Event >
- [Activity Report] The 9th Nikkei FT Communicable Diseases Conference – The AMR Consortium of the Asia Africa Medical Innovation Consortium (AMIC) (November 16, 2022)
The AMR Consortium of the Asia Africa Medical Innovation Consortium, for which AMR Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) serves as the secretariat, discussed future AMR countermeasures during the 9th NIKKEI FT Communicable Diseases Conference, organized by Nikkei INC. and co-sponsored by Financial Times.
During the discussion, participants shared future challenges regarding AMR countermeasures and reported on activities such as a “Survey to Identify Key Messages for Public Understanding of the Threat of Antimicrobial Resistance (AMR)” and “Recommendations of the G7 Hiroshima Summit in 2023 Necessary Actions for AMR Control, Starting with the Introduction of Pull Incentives.”
■Overview (titles omitted)
Date: November 16, 2022 (Wed)
Program: Agenda 6 – AMR
NIKKEI FT Infectious Diseases Conference Chairs
Shigeru Omi (Japan Anti-Tuberculosis Association, Chairman, Representative, Board of Director / World Health Organization (WHO), Regional Office for Western Pacific)
Nahoko Shindo (Senior Advisor, WHO Health Emergencies Programme (WHE), World Health Organization)
Agenda 6 – AMR
Moderator
Kazuhiro Tateda (Department of Microbiology and Infectious Diseases / Toho University School of Medicine Professor)
Presentation
Dame Sally Davis (UK Government Special Envoy on Antimicrobial Resistance / UK Department of Health and Social Care)
Dagmar Reitenbach (Head of the Global Health Team, German Federal Ministry of Health)
Discussion (Japanese syllabary order)
Norio Ohmagari (National Center for Global Health and Medicine Hospital Disease Control and Prevention Center Director)
Kazumasa Oguro (Hosei University School of Economics Professor)
Kanako Kitahara (Office for COVID-19 and Other Emerging Infectious Disease Control / Counsellor: Cabinet Secretariat, Government of Japan)
Shinichi Kohguchi (Senior Stewardship Officer Stewardship Development Department, Sumitomo Mitsui Trust Asset Management Co., Ltd.)
Takuko Sawada (Director and Vice Chairperson of the Board, Shionogi & Co., Ltd.)
Atsunobu Takeshita (President and Chief Executive Officer Publisher NIKKEI Science, INC.)
Yasunori Tawaragi (Environmental Management and Global Health Group Sustainability Promotion Department, DAIICHI SANKYO CO., LTD.)
Eiji Hinoshita (Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare of Japan)
Greg Frank (Director, Global Public Policy, MSD)
Mitsuru Miyata (Miyata Institute of Technologies, K.K.)